Capitale Di Prestito Cambiamento Data
Ardelyx USD 251.82M 48.31M 2026-06
Baxter International USD 8.62B 6M 2026-06
Bayer EUR 37.7B 6.54B 2026-09
BioCryst Pharmaceuticals USD 395.61M 209K 2026-09
Biogen USD 7.29B 1.7M 2026-09
BioMarin Pharmaceutical USD 3.51B 12.96M 2026-09
Emergent BioSolutions USD 446.5M 1.7M 2023-12
Gilead Sciences USD 23.82B 17M 2026-09
GlaxoSmithKline GBP 21.7B 7.75B 2026-09
Halozyme Therapeutics USD 2.94B 1.01B 2026-09
Insmed USD 544.86M 1.35M 2026-09
Ionis Pharmaceuticals USD 1.77B 140.62M 2026-09
J&J USD 35.8B 1.55B 2026-09
Lexicon Pharmaceuticals USD 49.68M 276K 2026-03
Moderna USD 3.55B 2.95B 2026-09
Omeros USD 403.72M 27.2M 2024-06
Pfizer USD 60B 498M 2026-09
PTC Therapeutics USD 536.27M 749K 2026-09
Regeneron Pharmaceuticals USD 1.99B 400K 2026-09
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 699.39M 148.23M 2026-09
Teva Pharmaceutical Industries USD 12.68B 588M 2026-09
United Therapeutics USD 100M 100M 2024-06
Vertex Pharmaceuticals USD 3.5B 3.39B 2026-09